Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Cantor Fitzgerald
Deloitte
Mallinckrodt
QuintilesIMS
Merck
Harvard Business School
Colorcon

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ARFORMOTEROL TARTRATE

« Back to Dashboard

Clinical Trials for Arformoterol Tartrate

Trial ID Title Status Sponsor Phase Summary
NCT00250679 Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease Completed Sunovion Phase 3 To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a period of 6 months in subjects with chronic obstructive pulmonary disease (COPD).
NCT00424528 Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) Completed Sunovion Phase 4 The purpose of this study is to evaluate and compare the efficacy of arformoterol twice a day and tiotropium once a day (dosed sequentially) versus tiotropium once a day alone in subjects with Chronic Obstructive Pulmonary Disease (COPD).
NCT00571428 Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD Completed Sunovion Phase 4 To evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol tartrate inhalation solution 15μg/2 mL BID in subjects with COPD.
NCT00583947 A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects Completed Sunovion Phase 2 To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Arformoterol Tartrate

Condition Name

Condition Name for Arformoterol Tartrate
Intervention Trials
Chronic Obstructive Pulmonary Disease 5
Emphysema 3
Bronchitis 2
COPD 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Arformoterol Tartrate
Intervention Trials
Lung Diseases, Obstructive 7
Lung Diseases 7
Pulmonary Disease, Chronic Obstructive 7
Emphysema 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Arformoterol Tartrate

Trials by Country

Trials by Country for Arformoterol Tartrate
Location Trials
United States 104
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Arformoterol Tartrate
Location Trials
South Carolina 7
California 6
Oregon 5
North Carolina 5
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Arformoterol Tartrate

Clinical Trial Phase

Clinical Trial Phase for Arformoterol Tartrate
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Arformoterol Tartrate
Clinical Trial Phase Trials
Completed 6
Terminated 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Arformoterol Tartrate

Sponsor Name

Sponsor Name for Arformoterol Tartrate
Sponsor Trials
Sunovion 8
University of California, Los Angeles 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Arformoterol Tartrate
Sponsor Trials
Industry 8
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
US Department of Justice
Dow
Cantor Fitzgerald
Cipla
UBS
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.